Paper3497883
In vivo anti-tumor activity of combinations of interferon alpha and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells.
Brunda MJ and 2 others. Int J Cancer, 1987. Cited by 155 papers, by iCite.
Cite this record
ConductScience Library. In vivo anti-tumor activity of combinations of interferon alpha and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells. Papers, record 3497883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3497883
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vivo anti-tumor activity of combinations of interferon alpha and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferon Type I | Major topic |
| Interleukin-2 | Major topic |
| Killer Cells, Natural | Major topic |
| Neoplasms, Experimental | Major topic |
| Animals | |
| Female | |
| Mice | |
| Mice, Inbred C57BL | |
| Neoplasm Metastasis | |
| Recombinant Proteins |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 155 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27313471 | Anti-colorectal cancer effect of interleukin-2 and interferon-β fusion gene driven by carcinoembryonic antigen promoter. | Onco Targets Ther | 2016 | https://conductscience.org/library/papers/27313471 | PubMed |
| 12622456 | Treatment of low-grade diffuse astrocytomas by surgery and human fibroblast interferon without radiation therapy. | J Neurooncol | 2003 | https://conductscience.org/library/papers/12622456 | PubMed |
| 11917944 | Kidney cancer: the Cytokine Working Group experience (1986-2001): part I. IL-2-based clinical trials. | Med Oncol | 2001 | https://conductscience.org/library/papers/11917944 | PubMed |
| 11114704 | Alleviating oxidative stress in cancer immunotherapy: a role for histamine? | Med Oncol | 2000 | https://conductscience.org/library/papers/11114704 | PubMed |
| 10411104 | Effects of immunization with tumor cells double transfected with interleukin-2 (IL-2) and interleukin-12 (IL-12) genes on artificial metastasis of colon26 cells in BALB/c mice. | Clin Exp Metastasis | 1999 | https://conductscience.org/library/papers/10411104 | PubMed |
| 8299113 | Curative effects of combination therapy with lentinan and interleukin-2 against established murine tumors, and the role of CD8-positive T cells. | Cancer Immunol Immunother | 1994 | https://conductscience.org/library/papers/8299113 | PubMed |
| 8242661 | Phenotypic and functional profile of peripheral blood mononuclear cells isolated from melanoma patients undergoing combined immunotherapy and chemotherapy. | Cancer Immunol Immunother | 1993 | https://conductscience.org/library/papers/8242661 | PubMed |
| 8104230 | Antitumor and antimetastatic activity of interleukin 12 against murine tumors. | J Exp Med | 1993 | https://conductscience.org/library/papers/8104230 | PubMed |
| 8001030 | Histamine in immunotherapy of advanced melanoma: a pilot study. | Cancer Immunol Immunother | 1994 | https://conductscience.org/library/papers/8001030 | PubMed |
| 7923989 | Enhanced therapeutic effects of anti-tumour agents against growth and metastasis of colon carcinoma 26 when given in combination with interferon and interleukin-2. | Clin Exp Metastasis | 1994 | https://conductscience.org/library/papers/7923989 | PubMed |
| 7852191 | Synergistic antimetastatic effects of lentinan and interleukin 2 with pre- and post-operative treatments. | Jpn J Cancer Res | 1994 | https://conductscience.org/library/papers/7852191 | PubMed |
| 7779731 | Final report of a phase II study of interleukin 2 and interferon alpha in patients with metastatic melanoma. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7779731 | PubMed |
| 7678979 | Immunomodulation during prolonged treatment with combined interleukin-2 and interferon-alpha in patients with advanced malignancy. | Br J Cancer | 1993 | https://conductscience.org/library/papers/7678979 | PubMed |
| 2786729 | Effects of interleukin-2 and interferon-alpha A/D treatment on lymphocytes from tumour-bearing mice. | Br J Cancer | 1989 | https://conductscience.org/library/papers/2786729 | PubMed |
| 2785852 | Synergistic induction of lymphokine (IL-2)-activated killer activity by IL-2 and the polysaccharide lentinan, and therapy of spontaneous pulmonary metastases. | Cancer Immunol Immunother | 1989 | https://conductscience.org/library/papers/2785852 | PubMed |
| 2598180 | Therapeutic efficacy of human recombinant interleukin-2 (TGP-3) alone or in combination with cyclophosphamide and immunocompetent cells in allogeneic, semi-syngeneic, and syngeneic murine tumors. | Cancer Immunol Immunother | 1989 | https://conductscience.org/library/papers/2598180 | PubMed |
| 2513305 | Combination therapy of colon carcinoma 26 in mice with recombinant human interleukin-2 and interferon-alpha A/D: occurrence of large granular cells in the tumor. | Jpn J Cancer Res | 1989 | https://conductscience.org/library/papers/2513305 | PubMed |
| 2503476 | Enhancement of therapeutic effect of interleukin-2 on spontaneous pulmonary metastases of Lewis lung carcinoma by killer helper factor associated with increased induction of killer activity. | Jpn J Cancer Res | 1989 | https://conductscience.org/library/papers/2503476 | PubMed |
| 2495179 | Combined effects of interferon alpha and interleukin 2 on the induction of a vascular leak syndrome in mice. | Cancer Immunol Immunother | 1989 | https://conductscience.org/library/papers/2495179 | PubMed |
| 2407894 | Cancer, cytokines, and cytotoxic cells: interleukin-2 in the immunotherapy of human neoplasms. | Klin Wochenschr | 1990 | https://conductscience.org/library/papers/2407894 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3497883
GET https://conductscience.org/api/papers/v1/3497883/cited_by?page=2